CHANNELS

Subscribe to the InfoTech eNewsletter

infoTECH News

TMCNet:  Research and Markets: Global Choroidal Neovascularization (CNV) Market 2014-2018 with Bayer, F. Hoffmann-La Roche, Novartis & Regeneron Pharmaceuticals Dominating

[June 24, 2014]

Research and Markets: Global Choroidal Neovascularization (CNV) Market 2014-2018 with Bayer, F. Hoffmann-La Roche, Novartis & Regeneron Pharmaceuticals Dominating

DUBLIN --(Business Wire)--

Research and Markets (http://www.researchandmarkets.com/research/lmfgqx/global_choroidal) has announced the addition of the "Global Choroidal Neovascularization (CNV) Market 2014-2018" report to their offering.

The current competition in the Global CNV market is strong as the available treatment options and marketed products have been successful in meeting the market requirement, while treating the underlying cause of the disease.

The current market drugs include Lucentis, approved for CNV associated with wet AMD (News - Alert); Macugen, approved for CNV associated with wet AMD; and Visudyne, approved for CNV associated with wet AMD, presumed ocular histoplasmosis, and pathologic myopia. Apart from these, Avastin, which is currently used as an off-label drug has gradually captured a major share of the market. In addition, the CNV pipeline seems to be promising with various molecules in the development phase. These products are expeced to meet the unmet needs in the market and will provide physicians with a wider choice in treating CNV.

The Global CNV market is driven by several factors, of which high patient and physician satisfaction is one of the major drivers. High patient and physician satisfaction has resulted in increased demand for CNV treatment therapies.

Further, the report states that one of the major challenges is the high cost of treatment. Many patients do not have the required budget for investing in high cost treatment options.

Key Vendors

  • Bayer AG
  • F. Hoffmann-La Roche Ltd.
  • Novartis AG
  • Regeneron Pharmaceuticals Inc.

Other Prominent Vendors

  • Affitech A/S
  • Allergan Inc.
  • Chengdu Kanghong Biotech Co. Ltd.
  • Gilead Sciences Inc.
  • Lpath Inc.
  • Mat Biopharma SAS (News - Alert)
  • Pfizer Inc.
  • Promedior Inc.
  • QLT Inc.
  • Quark Pharmaceuticals Inc.
  • Resolvyx Pharmaceuticals Inc.
  • Sanwa Kagaku Kenkyusho Co. Ltd.
  • Valeant Pharmaceuticals International Inc.

Key Topics Covered:

  1. Executive Summary
  2. List of Abbreviations
  3. Scope of the Report
  4. Product Profiles
  5. Market Research Methodology
  6. Introduction
  7. Market Landscape
  8. Product Portfolio of Current CNV Therapies
  9. Clinical Pipeline Portpolio
  10. Rate of Incidence and Prevalence
  11. Geographical Segmentation
  12. Buying Criteria
  13. Market Growth Drivers
  14. Drivers and their Impact
  15. Market Challenges
  16. Impact of Drivers and Challenges
  17. Market Trends
  18. Trends and their Impact
  19. Vendor Landscape

For more information visit http://www.researchandmarkets.com/research/lmfgqx/global_choroidal


[ InfoTech Spotlight's Homepage ]


blog comments powered by Disqus

FOLLOW US

Subscribe to InfoTECH Spotlight eNews

InfoTECH Spotlight eNews delivers the latest news impacting technology in the IT industry each week. Sign up to receive FREE breaking news today!
FREE eNewsletter